Table 4 Baseline characteristics of HCV mono-infected patients (HCV treated versus untreated)
Characteristics | Group A: HCV mono-infected patients, treated (n = 52) | Group B: HCV mono-infected patients, untreated (n = 32) | p-values |
|---|---|---|---|
Age, mean (min./max.) | 44 (22/65) | 48 (20/72) | 0.112 |
Sex, male/female (%) | 34/18 (65/35) | 17/15 (53/47) | 0.264 |
Genotype, n (%) | |||
1 | 27 (52) | 22 (69) | 0.129 |
2 | 8 (15) | 1 (3) | 0.078 |
3 | 12 (23) | 3 (9) | 0.111 |
4 | 4 (8) | 1 (3) | 0.390 |
Unknown | 1 (2) | 5 (16) | 0.018 |
Transmission, n (%) | |||
IVDU | 28 (54) | 14 (44) | 0.369 |
Transfusion | 2 (4) | 4 (13) | 0.135 |
Needlestick injury | 2 (4) | 1 (3) | 0.863 |
Tatoo | 2 (4) | 0 (0) | 0.262 |
Unknown | 18 (35) | 13 (41) | 0.579 |
HCV RNA in IU/ml, mean (min./max.) | 3 222 000 (3/2 × 107) | 3 810 000 (3/3 × 107) | 0.698 |
Liver biopsy, n (%) | 27/52 (51) | 9/32 (28) | 0.032 |
Fibrosis F3 – F4, n (%) | 8/27 (29) | 2/9 (22) | 0.209 |